Canada markets open in 8 hours 33 minutes

FSD Pharma Inc. (HUGE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
2.6000+0.0300 (+1.17%)
At close: 3:58PM EST
Currency in CAD

Valuation Measures

Market Cap (intraday) 549.82M
Enterprise Value 331.96M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)193.78
Price/Book (mrq)0.91
Enterprise Value/Revenue 3124.30
Enterprise Value/EBITDA 6-0.78

Trading Information

Stock Price History

Beta (5Y Monthly) 1.16
52-Week Change 3-56.67%
S&P500 52-Week Change 326.90%
52 Week High 314.7400
52 Week Low 30.0000
50-Day Moving Average 32.9111
200-Day Moving Average 32.8094

Share Statistics

Avg Vol (3 month) 391.36k
Avg Vol (10 day) 377.25k
Shares Outstanding 519.16M
Float 16.43M
% Held by Insiders 112.70%
% Held by Institutions 10.73%
Shares Short (Jan. 14, 2021) 425.58k
Short Ratio (Jan. 14, 2021) 40.53
Short % of Float (Jan. 14, 2021) 4N/A
Short % of Shares Outstanding (Jan. 14, 2021) 40.13%
Shares Short (prior month Dec. 14, 2020) 488.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:201
Last Split Date 3Oct. 15, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-18,162.76%

Management Effectiveness

Return on Assets (ttm)-46.20%
Return on Equity (ttm)-104.98%

Income Statement

Revenue (ttm)257.1k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-3.33M
EBITDA -41.04M
Net Income Avi to Common (ttm)-54.58M
Diluted EPS (ttm)-5.8400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.66M
Total Cash Per Share (mrq)0.97
Total Debt (mrq)1.37M
Total Debt/Equity (mrq)3.23
Current Ratio (mrq)2.62
Book Value Per Share (mrq)2.87

Cash Flow Statement

Operating Cash Flow (ttm)-23.07M
Levered Free Cash Flow (ttm)-13.29M